Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer

Torre, 2016, Lung cancer statistics, Adv. Exp. Med. Biol., 893, 1, 10.1007/978-3-319-24223-1_1 Cataldo, 2011, Treatment of non-small-cell lung cancer with erlotinib or gefitinib, N. Engl. J. Med., 364, 947, 10.1056/NEJMct0807960 Mandal, 2016, Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer, Eur. J. Pharm. Sci., 81, 162, 10.1016/j.ejps.2015.10.021 Shien, 2014, Drug resistance to EGFR tyrosine kinase inhibitors for non-small cell lung cancer, Acta Med. Okayama, 68, 191 Ramasamy, 2017, Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review, J. Control. Release, 258, 226, 10.1016/j.jconrel.2017.04.043 Anselmo, 2013, Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells, ACS Nano, 7, 11129, 10.1021/nn404853z Ramasamy, 2017, Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors, Acta Biomater., 48, 131, 10.1016/j.actbio.2016.10.034 Ramasamy, 2014, Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs, Acta Biomater., 10, 5116, 10.1016/j.actbio.2014.08.021 Kaur, 2013, p300/CBP dependent hyperacetylation of histone potentiates anticancer activity of gefitinib nanoparticles, Biochim. Biophys. Acta, 1833, 1028, 10.1016/j.bbamcr.2013.01.029 Marslin, 2009, Poly(d,l-lactic-co-glycolic acid) nanoencapsulation reduces erlotinib-induced subacute toxicity in rat, J. Biomed. Nanotechnol., 5, 464, 10.1166/jbn.2009.1075 Noorani, 2017, Erlotinib-loaded albumin nanoparticles: a novel injectable form of erlotinib and its in vivo efficacy against pancreatic adenocarcinoma ASPC-1 and PANC-1 cell lines, Int. J. Pharm., 531, 299, 10.1016/j.ijpharm.2017.08.102 Barghi, 2014, Synthesis, characterization and in vitro anti-tumoral evaluation of erlotinib-PCEC nanoparticles, Asian Pac. J. Cancer Prev., 15, 10281, 10.7314/APJCP.2014.15.23.10281 Vrignaud, 2012, Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride, Int. J. Pharm., 436, 194, 10.1016/j.ijpharm.2012.06.026 Fathi, 2017, Folate-conjugated thermosensitive O-maleoyl modified chitosan micellar nanoparticles for targeted delivery of erlotinib, Carbohydr. Polym., 172, 130, 10.1016/j.carbpol.2017.05.007 Xu, 2017, Novel therapeutic modalities and drug delivery - erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations, Artif. Cells Nanomed. Biotechnol., 1, 10.1080/21691401.2017.1396222 Morton, 2014, A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways, Sci. Signal., 7, ra44, 10.1126/scisignal.2005261 Kim, 2017, PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer, Colloids Surf. B: Biointerfaces, 150, 393, 10.1016/j.colsurfb.2016.11.002 Lam, 2014, Adsorption and desorption of tyrosine kinase inhibitor erlotinib on gold nanoparticles, J. Colloid Interface Sci., 425, 96, 10.1016/j.jcis.2014.03.032 Fathi, 2018, Thermo-sensitive chitosan copolymer-gold hybrid nanoparticles as a nanocarrier for delivery of erlotinib, Int. J. Biol. Macromol., 106, 266, 10.1016/j.ijbiomac.2017.08.020 Gao, 2012, Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-beta-cyclodextrin inclusion complex-loaded albumin nanoparticles, Int. J. Pharm., 427, 410, 10.1016/j.ijpharm.2012.01.054 Onnainty, 2016, Permeability profiles and intestinal toxicity assessment of hydrochlorothiazide and its inclusion complex with beta-cyclodextrin loaded into chitosan nanoparticles, Mol. Pharm., 13, 3736, 10.1021/acs.molpharmaceut.6b00532 Sajeesh, 2006, Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery, Int. J. Pharm., 325, 147, 10.1016/j.ijpharm.2006.06.019 Tang, 2017, Dimethyl-beta-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release, Carbohydr. Polym., 156, 215, 10.1016/j.carbpol.2016.09.038 Gupta, 2011, PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-beta-cyclodextrin (PGE1-HPbetaCD) complex for the treatment of pulmonary arterial hypertension (PAH), Pharm. Res., 28, 1733, 10.1007/s11095-011-0409-6 Swarnakar, 2013, Effect of co-administration of CoQ10-loaded nanoparticles on the efficacy and cardiotoxicity of doxorubicin-loaded nanoparticles, RSC Adv., 3, 14671, 10.1039/c3ra41107a Preet, 2012, Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity, Int. J. Cancer, 130, 1660, 10.1002/ijc.26158 Baek, 2016, Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time, Onco. Targets Ther., 9, 7207, 10.2147/OTT.S112566 Mohapatra, 2016, Spectral mapping of 3D multi-cellular tumor spheroids: time-resolved confocal microscopy, Phys. Chem. Chem. Phys., 18, 18381, 10.1039/C6CP02748B Devasari, 2015, Inclusion complex of erlotinib with sulfobutyl ether-beta-cyclodextrin: preparation, characterization, in silico, in vitro and in vivo evaluation, Carbohydr. Polym., 134, 547, 10.1016/j.carbpol.2015.08.012 Franken, 2006, Clonogenic assay of cells in vitro, Nat. Protoc., 1, 2315, 10.1038/nprot.2006.339 Heydt, 2018, Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance, Oncotarget, 9, 15418, 10.18632/oncotarget.24624 Anichini, 2018, The non-small cell lung cancer immune landscape: emerging complexity, prognostic relevance and prospective significance in the context of immunotherapy, Cancer Immunol. Immunother., 67, 1011, 10.1007/s00262-018-2147-7 Riccardi, 2006, Analysis of apoptosis by propidium iodide staining and flow cytometry, Nat. Protoc., 1, 1458, 10.1038/nprot.2006.238 Boulares, 1999, Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells, J. Biol. Chem., 274, 22932, 10.1074/jbc.274.33.22932 Liu, 2017, Role of autophagy and apoptosis in non-small-cell lung cancer, Int. J. Mol. Sci., 18, 10.3390/ijms18020367 Huang, 2015, Nanoparticles modulate autophagic effect in a dispersity-dependent manner, Sci. Rep., 5 Wei, 2017, New findings of silica nanoparticles induced ER autophagy in human colon cancer cell, Sci. Rep., 7 Wang, 2017, Silica nanoparticles induce autophagy dysfunction via lysosomal impairment and inhibition of autophagosome degradation in hepatocytes, Int. J. Nanomedicine, 12, 809, 10.2147/IJN.S123596 Han, 2011, EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells, PLoS One, 6, 10.1371/journal.pone.0018691 Goodman, 2008, 3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers, Bioconjug. Chem., 19, 1951, 10.1021/bc800233a Wang, 2013, Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles, Biomaterials, 34, 4667, 10.1016/j.biomaterials.2013.03.008 Sims, 2017, Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue, J. Nanobiotechnol., 15, 67, 10.1186/s12951-017-0298-x